chr5-42423803-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000163.5(GHR):​c.-164A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.823 in 164,420 control chromosomes in the GnomAD database, including 55,987 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 51557 hom., cov: 34)
Exomes 𝑓: 0.84 ( 4430 hom. )

Consequence

GHR
NM_000163.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.624

Publications

2 publications found
Variant links:
Genes affected
GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
GHR Gene-Disease associations (from GenCC):
  • Laron syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • short stature due to partial GHR deficiency
    Inheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 5-42423803-A-G is Benign according to our data. Variant chr5-42423803-A-G is described in ClinVar as [Benign]. Clinvar id is 353676.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHRNM_000163.5 linkc.-164A>G 5_prime_UTR_variant Exon 1 of 10 ENST00000230882.9 NP_000154.1 P10912-1
GHRNM_001242460.2 linkc.-164A>G 5_prime_UTR_variant Exon 1 of 9 NP_001229389.1 P10912-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHRENST00000230882.9 linkc.-164A>G 5_prime_UTR_variant Exon 1 of 10 1 NM_000163.5 ENSP00000230882.4 P10912-1

Frequencies

GnomAD3 genomes
AF:
0.822
AC:
124734
AN:
151728
Hom.:
51507
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.800
Gnomad AMI
AF:
0.776
Gnomad AMR
AF:
0.840
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.850
Gnomad FIN
AF:
0.922
Gnomad MID
AF:
0.723
Gnomad NFE
AF:
0.805
Gnomad OTH
AF:
0.804
GnomAD4 exome
AF:
0.836
AC:
10527
AN:
12586
Hom.:
4430
Cov.:
0
AF XY:
0.834
AC XY:
7787
AN XY:
9342
show subpopulations
African (AFR)
AF:
0.810
AC:
136
AN:
168
American (AMR)
AF:
0.866
AC:
142
AN:
164
Ashkenazi Jewish (ASJ)
AF:
0.720
AC:
59
AN:
82
East Asian (EAS)
AF:
1.00
AC:
470
AN:
470
South Asian (SAS)
AF:
0.867
AC:
896
AN:
1034
European-Finnish (FIN)
AF:
0.947
AC:
125
AN:
132
Middle Eastern (MID)
AF:
0.700
AC:
35
AN:
50
European-Non Finnish (NFE)
AF:
0.825
AC:
8261
AN:
10012
Other (OTH)
AF:
0.850
AC:
403
AN:
474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.822
AC:
124836
AN:
151834
Hom.:
51557
Cov.:
34
AF XY:
0.829
AC XY:
61523
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.800
AC:
33172
AN:
41472
American (AMR)
AF:
0.840
AC:
12826
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.770
AC:
2674
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5138
AN:
5144
South Asian (SAS)
AF:
0.850
AC:
4092
AN:
4814
European-Finnish (FIN)
AF:
0.922
AC:
9684
AN:
10502
Middle Eastern (MID)
AF:
0.729
AC:
210
AN:
288
European-Non Finnish (NFE)
AF:
0.805
AC:
54644
AN:
67872
Other (OTH)
AF:
0.806
AC:
1690
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1168
2336
3504
4672
5840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.819
Hom.:
6368
Bravo
AF:
0.814
Asia WGS
AF:
0.928
AC:
3179
AN:
3426

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 11, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Laron-type isolated somatotropin defect Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
13
DANN
Benign
0.68
PhyloP100
-0.62
PromoterAI
0.029
Neutral
Mutation Taster
=296/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2940928; hg19: chr5-42423905; API